Shares of drugstore operator and pharmacy benefits manager CVS Caremark Corp. are approaching their full value according to a BMO Capital analyst who lowered his rating on the stock to "market perform" from "outperform."
Analyst Dave Shove said in a Monday night research note that company shares are trading at about 12.3 times his estimate for adjusted 2013 earnings per share. His $47 price target on the stock represents a 2013 price to earnings multiple of nearly12.75.
"We continue to believe that solid execution and external market dynamics have positioned the company for good growth in the near term but feel shares now reflect much of the anticipated earnings expansion," Shove wrote, adding that competitors like Catalyst Health Solutions Inc. provide more of an opportunity for share appreciation.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
